These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7683008)

  • 1. In vitro histamine release induced by magnetic resonance imaging and iodinated contrast media.
    Baxter AB; Lazarus SC; Brasch RC
    Invest Radiol; 1993 Apr; 28(4):308-12. PubMed ID: 7683008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast media are incomplete secretagogues acting on human basophils and mast cells isolated from heart and lung, but not skin tissue.
    Genovese A; Stellato C; Patella V; Lamparter-Schummert B; de Crescenzo G; Adt M; Marone G
    Int J Clin Lab Res; 1996; 26(3):192-8. PubMed ID: 8905451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of a previous allergy to an iodinated contrast agent in the administration of gadopentetate dimeglumine.
    García N; Ramón E; Gonzalez del Valle L; Ruano M; Jiménez E
    Ann Pharmacother; 1997 Mar; 31(3):374. PubMed ID: 9066954
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
    Campos A; Aznar L; Alamar R; Castelló JV
    Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023
    [No Abstract]   [Full Text] [Related]  

  • 5. Case of anaphylaxis and four cases of allergic reaction following Gd-DTPA administration.
    Salonen OL
    J Comput Assist Tomogr; 1990; 14(6):912-3. PubMed ID: 2229566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe anaphylactoid reaction after i.v. Gd-DTPA.
    Weiss KL
    Magn Reson Imaging; 1990; 8(6):817-8. PubMed ID: 2266810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anaphylactoid reaction after intravenous administration of Gd-DTPA].
    Katoh A; Kishikawa T; Kudo S; Matsubayashi R; Takagi N; Nishihara G
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Aug; 53(8):973-5. PubMed ID: 8371946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaphylactoid reactions to i.v. gadopentetate dimeglumine.
    Tishler S; Hoffman JC
    AJNR Am J Neuroradiol; 1990; 11(6):1167; discussion 1168-9. PubMed ID: 2124049
    [No Abstract]   [Full Text] [Related]  

  • 9. Is a mixture of gadolinium and iodinated contrast material safe during MR arthrography?
    Brown RR; Clarke DW; Daffner RH
    AJR Am J Roentgenol; 2000 Oct; 175(4):1087-90. PubMed ID: 11000170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal tolerance of gadolinium-DOTA and gadolinium-DTPA in rats.
    Brillet G; Dubois M; Beaufils H; Bourbouze R; Deray G
    Invest Radiol; 1994 Mar; 29(3):352-4. PubMed ID: 8175311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadopentetate dimeglumine and iodinated contrast media. Hemodynamic side effects after bolus injections in pigs.
    Kuhtz-Buschbeck JP; Ehrhardt K; Köhnlein S; Radtke W; Heintzen P
    Invest Radiol; 1997 Feb; 32(2):111-9. PubMed ID: 9039584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal reaction to gadopentetate dimeglumine.
    Jordan RM; Mintz RD
    AJR Am J Roentgenol; 1995 Mar; 164(3):743-4. PubMed ID: 7863905
    [No Abstract]   [Full Text] [Related]  

  • 13. Anaphylactic shock induced by gadoterate meglumine (DOTAREM).
    Beaudouin E; Kanny G; Blanloeil Y; Guilloux L; Renaudin JM; Moneret-Vautrin DA
    Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):382-5. PubMed ID: 14768523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of dotarem (Gd-DOTA) versus magnevist (Gd-DTPA) in magnetic resonance imaging of the central nervous system.
    Oudkerk M; Sijens PE; Van Beek EJ; Kuijpers TJ
    Invest Radiol; 1995 Feb; 30(2):75-8. PubMed ID: 7782190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse reactions during intravenous urography: are these due to histamine release?
    Herd CM; Robertson AR; Frewin DB; Taylor WB
    Br J Radiol; 1988 Jan; 61(721):5-11. PubMed ID: 2450612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe anaphylactoid reaction to Gd-DTPA.
    Lufkin RB
    Radiology; 1990 Sep; 176(3):879. PubMed ID: 2389057
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and tolerance after intravenous administration of 0.3 mmol/kg Gd-DTPA. Results of a randomized, controlled clinical trial.
    Niendorf HP; Haustein J; Louton T; Beck W; Laniado M
    Invest Radiol; 1991 Nov; 26 Suppl 1():S221-3; discussion S232-5. PubMed ID: 1808134
    [No Abstract]   [Full Text] [Related]  

  • 18. Histamine release from canine lung and liver mast cells induced by radiographic contrast media.
    Ennis M; Amon EU; Lorenz W
    Agents Actions; 1989 Apr; 27(1-2):101-3. PubMed ID: 2473612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oral contrast media for the magnetic resonance tomography of the abdomen. A clinical trial of the tolerance for gadolinium-DTPA].
    Kaminsky S; Laniado M; Gogoll M; Kornmesser W; Clauss W; Felix R
    Rofo; 1992 Jan; 156(1):17-23. PubMed ID: 1733470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of intracellular Ca2+ and cyclic AMP in mast cell histamine release induced by radiographic contrast media.
    Saito M; Itoh Y; Yano T; Sendo T; Goromaru T; Sakai N; Oishi R
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):364-71. PubMed ID: 12690428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.